What are so ‘innovative’ about ‘NOAC’ applauded by physicians?

Foreign and domestic guidelines, recently, have aggressively recommended NOAC(New-Oral Anti-Coagulant) as an anticoagulant to prevent stoke and systemic embolism of atrial fibrillation patients.

Thus, NOAC has been available to acquire the health insurance benefit as the primary treatment since the 1^st of July in the domestic field. It used to be limited only to patients failed to use warfarin...